TABLE 1

Characteristics of Patients with Stable CAD Undergoing Initial Diagnostic Evaluation with Either CAG or MPI

Overall (n = 137,066)
CharacteristicCAG (n = 117,134)MPI (n = 19,932)P
Age (y)60.6 ± 12.161.7 ± 12.2<0.001
Sex, male, n (%)63,912 (54.6)10,422 (52.3)<0.001
No. of patients enrolled (%)<0.001
 July 2009 to June 201023,985 (20.5)6,389 (32.1)
 July 2010 to June 201128,193 (24.1)5,513 (27.7)
 July 2011 to June 201231,583 (27.0)4,240 (21.3)
 July 2012 to June 201333,373 (28.5)3,790 (19.0)
No. of comorbid conditions (%)
 Diabetes23,380 (20.0)4,864 (24.4)<0.001
 Diabetes with chronic complications11,520 (9.8)2,115 (10.6)0.001
 Hyperlipidemia33,591 (28.7)6,995 (35.1)<0.001
 Hypertension52,629 (44.9)10,184 (51.1)<0.001
 Congestive heart failure6,844 (5.8)830 (4.2)<0.001
 Arrhythmia7,686 (6.6)1,492 (7.5)<0.001
 Valvular disease1,622 (1.4)269 (1.4)0.694
 Peripheral vascular disease13,869 (11.8)2,345 (11.8)0.761
 Cerebrovascular disease14,026 (12.0)2,522 (12.7)0.007
 Chronic pulmonary disease25,327 (21.6)4,076 (20.5)<0.001
 Moderate to severe liver disease416 (0.4)179 (0.9)<0.001
 Renal disease3,107 (2.7)991 (5.0)<0.001
 Cancer6,246 (5.3)2,993 (15.0)<0.001
 Rheumatic disease3,533 (3.0)817 (4.1)<0.001
 Charlson comorbidity index1.5 ± 1.82.0 ± 2.2<0.001
  • Data are expressed as n, with percentages in parentheses, and mean ± SD.